Heart failure & cardiomyopathiesTrial design
Peripartum Cardiomyopathy Genetic Screening Protocol and Registry
- prospective whole-genome sequencing and registry
- protocol
Study context
- Population
- Individuals meeting PPCM-ESC 2019 diagnostic criteria (left ventricular ejection fraction <45% or fractional shortening <30% with chamber dilation, onset between the last month of pregnancy and five months postpartum), Woman's Hospital, Louisiana
No results yet. This paper sets out the design of a trial; its results are to come.
Further findings
Study conduct
- The PERCVD Trial is enrolling patients, and clinical outcome data are not available
Original publication
Peripartum Cardiomyopathy Genetic Screening Protocol and Registry. JACC Adv. Published 25 September 2026. doi:10.1016/j.jacadv.2026.103286
Summarised from the published abstract; every number is checked against it